ÐÂÎÅ×ÊѶ
ÄÐÐÔµÄÇ¿Ê¢£¬£¬ £¬£¬ £¬£¬£¬£¬ÔÚÓÚ´ÓÈÝ¡ª¡ª¡ªÏ²±¨£¡º£ÄÚÊ׸ö£¡Î÷°àÑÀÔÑÐÈë¿ÚèÛéÚËáÎ÷µØÄÇ·Ç¿Ú·þ»ìÐüÒº»ñÅúÉÏÊУ¡
ÈÕÆÚ£º
2026Äê04ÔÂ03ÈÕ 14:35
èÛéÚËáÎ÷µØÄÇ·Ç¿Ú·þ»ìÐüÒº£¨ÐÒ·ö½¡®£©ÉÏÊÐÉêÇëÕýʽ»ñÅú¡£¡£¡£¡£¡£¡£×÷Ϊº£ÄÚÊ׸ö¿Ú·þ»ìÐüÒº¼ÁÐ͵ÄÎ÷µØÄÇ·Ç£¬£¬ £¬£¬ £¬£¬£¬£¬Õâ¿îÓÉÎ÷°àÑÀÔÑÐÉú²úµÄ²úÆ·£¬£¬ £¬£¬ £¬£¬£¬£¬²»µ«Ìî²¹ÁËED£¨²ªÆð¹¦Ð§ÕÏ°£©ÖÎÁÆÁìÓòµÄ¼ÁÐÍ¿Õȱ£¬£¬ £¬£¬ £¬£¬£¬£¬¸ü±ê¼Ç×ÅÄÐÐÔ¿µ½¡¹ÜÀíÂõÈëÁ˾«×¼¿ØÁ¿¡¢ÌåÑéÓÅÏȵÄн׶Ρ£¡£¡£¡£¡£¡£Ëü¼È·ÇÈ«ÐÂÒòËØ£¬£¬ £¬£¬ £¬£¬£¬£¬Ò²·ÇÊ׷£¬£¬ £¬£¬ £¬£¬£¬£¬¶øÊÇÖ±»÷»¼Õßδ±»Öª×ãµÄÓÃÒ©ÐèÇ󣬣¬ £¬£¬ £¬£¬£¬£¬ÒÔ¸ÄÁ¼ÐÍÐÂÒ©µÄ×Ë̬£¬£¬ £¬£¬ £¬£¬£¬£¬ÖØнç˵·þÒ©ÌåÑé——¸üÓÐÓ㬣¬ £¬£¬ £¬£¬£¬£¬¸üÌåÃ棬£¬ £¬£¬ £¬£¬£¬£¬¸ü´ÓÈÝ¡£¡£¡£¡£¡£¡£
Ò»¡¢Êг¡ÏÖ×´£ºEDÖÎÁÆÐèÇóÏÔÖø£¬£¬ £¬£¬ £¬£¬£¬£¬¹Å°åÓÃÒ©Í´µãÈÔ´æ
Ïֽ׶Î,EDÒѳÉΪӰÏìÄÐÐÔÉúÑÄÖÊÁ¿µÄÖ÷ÒªÎÊÌâÖ®Ò»¡£¡£¡£¡£¡£¡£ÔÚÎÒ¹úÓÐ×ÅÖØ´óµÄ»¼Õß»ùÊý¡£¡£¡£¡£¡£¡£¾Ý¹ûÕæÊý¾ÝÏÔʾ£¬£¬ £¬£¬ £¬£¬£¬£¬ÎÒ¹úED»¼ÕßÈËÊýÔ¼1.4ÒÚÈË¡£¡£¡£¡£¡£¡£¾Ý¡¶2024ÄêÖйú¿¹EDÒ©ÎïÐÐÒµ°×ƤÊé¡·ÏÔʾ£¬£¬ £¬£¬ £¬£¬£¬£¬31-40ËêÄÐÐÔÕ¼±È44.79%£¬£¬ £¬£¬ £¬£¬£¬£¬21-30ËêȺÌåÒ²µÖ´ï38.03%£¬£¬ £¬£¬ £¬£¬£¬£¬·ºÆðÄêÇữÇ÷ÊÆ¡£¡£¡£¡£¡£¡£
´ÓÊг¡¹æÄ£À´¿´£¬£¬ £¬£¬ £¬£¬£¬£¬EDÒ©ÎïÈüµÀÌåÁ¿¿É¹Û£¬£¬ £¬£¬ £¬£¬£¬£¬¶øÎ÷µØÄÇ·ÇÔÚËùÓÐEDÀàÒ©ÎïÊг¡Õ¼±È¶ÀÙÆ°ÁÍ·£¬£¬ £¬£¬ £¬£¬£¬£¬2024ÄêÕ¼±È¸ß´ï71.96%¡£¡£¡£¡£¡£¡£×÷ΪPDE5ÒÖÖƼÁµÄ½¹µãÆ·À࣬£¬ £¬£¬ £¬£¬£¬£¬Î÷µØÄǷǸüÊDZ»º£ÄÚÍâ¶àÏîȨÍþÖ¸ÄÏ£¨È硶²ªÆð¹¦Ð§ÕÏ°Õï¶ÏÓëÖÎÁÆÖ¸ÄÏ¡·¡¶Å·ÖÞÃÚÄòѧ»áÐÔÓëÉúÖ³¿µ½¡Ö¸ÄÏ¡·µÈ£©ÁÐΪEDÖÎÁƵÄÊ×Ñ¡Ò©Î£¬ £¬£¬ £¬£¬£¬£¬ÆäÓÐÓÃÐÔÓëÇå¾²ÐÔÒÑ»ñµÃÆÕ±éÑéÖ¤¡£¡£¡£¡£¡£¡£
Ö»¹Ü¿Ú·þPDE5ÒÖÖƼÁÊÇEDÖÎÁƵÄÖ÷Á÷Ñ¡Ôñ£¬£¬ £¬£¬ £¬£¬£¬£¬ÇÒ38.64%µÄÄÐÐÔÔø·þÓùý¿¹EDÒ©Îï1£¬£¬ £¬£¬ £¬£¬£¬£¬µ«¹Å°åƬ¼ÁµÄÍ´µãʼÖÕÄÑÒÔ½â¾ö£¬£¬ £¬£¬ £¬£¬£¬£¬³ÉΪ»¼ÕßÓÃÒ©µÄÒþÐÎÃż÷£º
¼ÁÁ¿Àο¿£ºÏÖÓе¥ºÐ°ü×°¼ÁÐͼÁÁ¿¾ùÒÑÀο¿£¬£¬ £¬£¬ £¬£¬£¬£¬ÎÞ·¨Æ¥Åä¸öÌ廯ÐèÇ󣻣»£»£» £»
ÐèË®ËÍ·þ£ºÎÞ·¨Öª×ãÎÞË®Ìõ¼þÏÂËæʱËæµØÔ½·¢±ã½Ý¸øÒ©£»£»£»£» £»
Òþ˽ÞÏÞΣºÒ©Æ¬°ü×°Ò×̻¶Òþ˽£¬£¬ £¬£¬ £¬£¬£¬£¬ÓÈÆäÔÚÉç½»³¡¾°ÏÂÓÃÒ©±ãµ±ÐÔ´ó·ùϽµ£»£»£»£» £»
ÍÌÑÊÕÏ°£ºÔ¼40.2£¥µÄÄÐÐÔ±£´æÍÌÑÊÄÑÌâ2£¬£¬ £¬£¬ £¬£¬£¬£¬Æ¬¼ÁÄÑÒÔÖª×ãÍÌÑÊÕÏ°ÕßÓÃÒ©ÐèÇ󡣡£¡£¡£¡£¡£
¶þ¡¢ÐÒ·ö½¡®£ºÒÔ¸ÄÁ¼ÊµÏÖÌåÑéÉý¼¶¾«×¼»÷ÖÐÁÙ´²Í´µã
ÐÒ·ö½¡®µÄÉÏÊУ¬£¬ £¬£¬ £¬£¬£¬£¬ÕýÊǶÔÕâËÄ´óÍ´µãµÄ¾«×¼»ØÓ¦£º
¾«×¼¼ÁÁ¿¶¨ÖÆ£º¼ÁÁ¿¿Éƾ֤ÐèÇóÎÞаµ÷Àí£¬£¬ £¬£¬ £¬£¬£¬£¬25-100mg×ÔÓɵ÷½â£¬£¬ £¬£¬ £¬£¬£¬£¬Æ¥Åä¸öÐÔ»¯ÐèÇ󣻣»£»£» £»
ʹÓÃÀû±ã¿ì½Ý£ºÎ¢·Û»¯Êèɢϵͳ£¬£¬ £¬£¬ £¬£¬£¬£¬ÎÞÐèË®ËÍ·þ£¬£¬ £¬£¬ £¬£¬£¬£¬ËæʱËæµØÍê³É¸øÒ©£¬£¬ £¬£¬ £¬£¬£¬£¬ÊÊÅä¶àÔªÉúÑij¡¾°£»£»£»£» £»
È«ÐÂÓÃÒ©ÌåÑ飺°Ñ“͵͵ÃþÃþÍÌƬ”Éý¼¶Îª“×Æ˸Õý´ó¿ÚÅç¸øÒ©”£¬£¬ £¬£¬ £¬£¬£¬£¬½â¾öÉç½»³¡¾°µÄÒþ˽ÞÏÞΡ£¡£¡£¡£¡£¡£
ÊÊÓÃÈËȺÆձ飺ÌØÊâÊʺÏÍÌÑÊÄÑÌâ¡¢Ðè׼ȷ¼ÁÁ¿µ÷½âµÄʹÓÃÕß
Èý¡¢´Ó“ÓÐÓÔµ½“ºÃÓÔ£ºÒ»³¡¹ØÓÚ·þÒ©ÌåÑéµÄÀíÄî¸ïÃü
ÐÒ·ö½¡®µÄ»ñÅú£¬£¬ £¬£¬ £¬£¬£¬£¬Ô¶·ÇÒ»´Î¼òÆӵļÁÐ͸ÄÁ¼£¬£¬ £¬£¬ £¬£¬£¬£¬¶øÊÇÒ»³¡¹ØÓÚEDÖÎÁƵÄÀíÄî¸ïÃü——ÎÒÃÇÕýÔÚÖØнç˵ʲô²ÅÊÇ“ºÃÒ©”¡£¡£¡£¡£¡£¡£
ºã¾ÃÒÔÀ´£¬£¬ £¬£¬ £¬£¬£¬£¬Ò½Ò©ÐÐÒµÖ´×ÅÓÚ×·ÇóÒ©ÎïµÄ“ÓÐÓÃÐÔ”£¬£¬ £¬£¬ £¬£¬£¬£¬È´ÍùÍùºöÂÔÁË“¿ÉÓÃÐÔ”¡£¡£¡£¡£¡£¡£µ±»¼ÕßÐèÒªêþҩƬ¡¢ÕÒË®±¡¢ÅÌËãʱ¼ä¡¢ÌÓ±ÜÑÛ¹âʱ£¬£¬ £¬£¬ £¬£¬£¬£¬Ò©ÎïµÄÁÆЧÒÑÔÚ²ã²ãÕÛËðÖдòÁËÕÛ¿Û¡£¡£¡£¡£¡£¡£
ÐÒ·ö½¡®µÄ·ºÆ𣬣¬ £¬£¬ £¬£¬£¬£¬±ê¼Ç×ÅEDÖÎÁÆÕýʽ´Ó“·þÒ©Öβ¡”µÄ1.0ʱ´ú£¬£¬ £¬£¬ £¬£¬£¬£¬ÂõÈë“ÌåÑéÓÅÏÈ”µÄ2.0ʱ´ú¡£¡£¡£¡£¡£¡£Õâ²»µ«ÊÇÊÖÒÕµÄÇ°½ø£¬£¬ £¬£¬ £¬£¬£¬£¬¸üÊǼÛÖµ¹ÛµÄת±ä£º
-
´Ó“»¼Õß˳ӦҩÎ½“Ò©Îï˳Ӧ»¼Õß”
-
´Ó“¼òµ¥¼ÁÁ¿”µ½“¸öÐÔ»¯¼Æ»®”
-
´Ó“Ò½ÁƳ¡¾°”µ½“ÉúÑij¡¾°”
-
´Ó“Öβ¡”µ½“ÖÎÐÄ”
“¸úÓÐÇéÈË×ö¿ìÀÖÊ£¬£¬ £¬£¬ £¬£¬£¬£¬±ðÎÊÊǽÙÊÇÔµ¡£¡£¡£¡£¡£¡£”Õâ¾äÀ´×Ô¡¶Á÷¹â°¿Ïè¡·µÄ¸è´Ê£¬£¬ £¬£¬ £¬£¬£¬£¬µÀ¾¡ÁËÈËÊÀÇé°®µÄ´¿´âÓëäìÈ÷¡£¡£¡£¡£¡£¡£¶øÒ»·Ý´ÓÈݵĵ×Æø£¬£¬ £¬£¬ £¬£¬£¬£¬ÕýÊÇÕâ“¿ìÀÖÊ”×îºÃµÄ×îÏÈ¡£¡£¡£¡£¡£¡£
ÏÖÔÚ£¬£¬ £¬£¬ £¬£¬£¬£¬ÐÒ·ö½¡® ÔÚÒ½Ò©ÁìÓòÕÒµ½ÁËеÄ×¢½Å——ÕæÕýµÄÖÎÁÆ£¬£¬ £¬£¬ £¬£¬£¬£¬Ó¦µ±Èû¼ÕßÔÚ×·Çó¿µ½¡µÄõ辶ÉÏ£¬£¬ £¬£¬ £¬£¬£¬£¬±£ÓÐÓ¦ÓеĴÓÈÝÓëÌåÃæ¡£¡£¡£¡£¡£¡£
ÎÒÃÇÆÚ´ýÓë¸÷½çЯÊÖ£¬£¬ £¬£¬ £¬£¬£¬£¬ÈÃÕⳡʼÓÚ¼ÁÐ͵ÄÀå¸ï£¬£¬ £¬£¬ £¬£¬£¬£¬×îÖÕÒý·¢Õû¸öÐÐÒµ¶Ô»¼ÕßÌåÑéµÄÖØйØ×¢¡£¡£¡£¡£¡£¡£ÓÉÓÚ£¬£¬ £¬£¬ £¬£¬£¬£¬×îºÃµÄÒ©£¬£¬ £¬£¬ £¬£¬£¬£¬²»µ«ÊÇÄÜÈò¡ÈËȬÓúµÄÒ©£¬£¬ £¬£¬ £¬£¬£¬£¬¸üÊÇÈò¡ÈËÔ¸Òâ¼á³Ö·þÓõÄÒ©¡£¡£¡£¡£¡£¡£
×ÊÁÏȪԴ
1¡¢2024ÄêÖйú¿¹EDÒ©ÎïÐÐÒµ°×ƤÊé
2¡¢Pharmacokinetic Parameters of a Novel SildenafiOral Liquid Suspension Administered to HealthyAdult Men Under Fasted Conditions
3¡¢ÖйúÌض¨ÈËȺÍÌÑʹ¦Ð§ÕÏ°µÄÊ¢Ðв¡Ñ§ÊӲ챨¸æ.ÖлªÎïÀíҽѧÓ뿵ÅÓºêÔ¸2017Äê12ÔµÚ39¾íµÚ12ÆÚ
4¡¢Ã×ÄÚÍøÊý¾Ý¿â¡¢²úÆ·ÁÙ´²Ñо¿Êý¾Ý
Ïà¹ØÍƼö
ÍøÕ¾½¨É裺ÖÐÆó¶¯Á¦ ̨ÖÝ